NEW YORK, July 26- Invitrogen announced a significant increase in second quarter revenues relative to the year ago period, largely due to the contribution of its newly acquired company, Life Technologies, the company announced on Thursday.

Invitrogen also posted a net loss of $35.1 million, or 67 cents per share, during this latest financial period, compared to a net income of $4.8 million in the second quarter, 2000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.